This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Latest papers
IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodents.
Diabetologia · 2017
Latest funding
- $543,295
Regulatory macrophages in islet inflammation and type 2 diabetes
CIHR · 2013 · Nominated PI
- $100,000
Targeting anti-inflammatory macrophages to treat type 2 diabetes
CIHR · 2011 · Nominated PI
- $100,000
The role of islet macrophages in obesity and type 2 diabetes: from pro-inflammation to regeneration.
CIHR · 2010 · Nominated PI
1 publications.
IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodents.
Ivovic A, Oprescu AI, Koulajian K, Mori Y, Eversley JA, Zhang L, Nino-Fong R, Lewis GF, Donath MY, Karin M, Wheeler MB, Ehses J, Volchuk A, Chan CB, Giacca A
Regulatory macrophages in islet inflammation and type 2 diabetes
Principal investigators: Ehses, Jan A
Keywords: Diabetes; Inflammation; Insulin; Islets Of Langerhans; Macrophages; Pancreatic Beta Cell
Targeting anti-inflammatory macrophages to treat type 2 diabetes
Principal investigators: Ehses, Jan A
Keywords: Diabetes; Inflammation; Insulin; Islets Of Langerhans; Macrophages; Pancreatic Beta Cell
The role of islet macrophages in obesity and type 2 diabetes: from pro-inflammation to regeneration.
Principal investigators: Ehses, Jan A
Keywords: Diabetes; Inflammation; Insulin; Islets Of Langerhans; Macrophages; Pancreatic Beta Cell; Regeneration
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.